| __timestamp | Galapagos NV | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 2652041 |
| Thursday, January 1, 2015 | 20309000 | 2361587 |
| Friday, January 1, 2016 | 16945000 | 4472869 |
| Sunday, January 1, 2017 | 20559000 | 5030957 |
| Monday, January 1, 2018 | 29641000 | 4988941 |
| Tuesday, January 1, 2019 | 88258000 | 5196412 |
| Wednesday, January 1, 2020 | 162170000 | 6652774 |
| Friday, January 1, 2021 | 167218000 | 18418247 |
| Saturday, January 1, 2022 | 239528000 | 24827066 |
| Sunday, January 1, 2023 | 94252000 | 41896408 |
| Monday, January 1, 2024 | 15488619 |
Cracking the code
In the competitive world of biotechnology, managing operational expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and Galapagos NV from 2014 to 2023. Galapagos NV, a Belgian biotech giant, has seen its SG&A expenses grow significantly, peaking in 2022 with a 2,500% increase from 2014. Opthea Limited, an Australian company, has also experienced a steady rise, with a notable 1,500% increase over the same period. Interestingly, 2023 marked a turning point for both companies, with Galapagos NV's expenses dropping by 60% from the previous year, while Opthea Limited's expenses surged by 68%. This divergence highlights the dynamic nature of the biotech industry, where strategic financial management can make or break a company's growth trajectory.
Operational Costs Compared: SG&A Analysis of Viatris Inc. and Galapagos NV
Comparing SG&A Expenses: BioMarin Pharmaceutical Inc. vs Opthea Limited Trends and Insights
Who Optimizes SG&A Costs Better? Blueprint Medicines Corporation or Galapagos NV
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Opthea Limited
Opthea Limited or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Opthea Limited and Merus N.V.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Opthea Limited vs MorphoSys AG Trends and Insights
Cost Management Insights: SG&A Expenses for Opthea Limited and Ligand Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: Opthea Limited vs Geron Corporation
Research and Development Investment: Opthea Limited vs Galapagos NV
Opthea Limited and Novavax, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Verona Pharma plc vs Galapagos NV